3081246-18-3
3081246-18-3
Chemical Structure
CDK9/EZH2-IN-1
- CAS No.: 3081246-18-3
- Formula:C47H59N11O4S2
- Molecular Weight:906.17
SMILES: CC1=CC(C)=C(C(N1)=O)CNC(C2=CC(C3=CC=C(N=C3)N4CCN(CC4)CCN5CCC(CC5)C(NC6=NC=C(S6)SCC7=NC=C(O7)C(C)(C)C)=O)=CC8=C2C=NN8C(C)C)=O
Biological Activity: CDK9/EZH2-IN-1 (Compound D16) is a CDK9/EZH2 dual-target inhibitor (IC50: 83.9/108.6 nM). CDK9/EZH2-IN-1 induces apoptosis and DNA double-strand breaks (DSBs). CDK9/EZH2-IN-1 inhibits the proliferation activity of MKN45, MDA-MB-453 and SW620 cancer cells (IC50 values are 136.3, 171.3 and 315.7 nM, respectively)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CDK9/EZH2-IN-1 | 99.08% | CDK9/EZH2-IN-1 (Compound D16) is a CDK9/EZH2 dual-target inhibitor (IC50: 83.9/108.6 nM). CDK9/EZH2-IN-1 induces apoptosis and DNA double-strand breaks (DSBs). CDK9/EZH2-IN-1 inhibits the proliferation activity of MKN45, MDA-MB-453 and SW620 cancer cells (IC50 values are 136.3, 171.3 and 315.7 nM, respectively). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
